INDV.NASDAQIndivior PLC

SCHEDULE: Two Seas Capital Reduces Indivior Stake Below 5%

Sentiment:

Beneficial Ownership Amendment


Two Seas Capital LP and its affiliates have reduced their beneficial ownership in Indivior PLC to 4.98%, falling below the 5% reporting threshold.

Capital raiseThe Litigation Fund's Ordinary Shares were purchased using working capital and proceeds from a Credit Facility provided by UBS AG, London Branch.The Credit Facility Agreement was originally dated June 16, 2022, and has been amended and restated multiple times, most recently on December 20, 2024, by the Sixth Amendment Agreement.

Summary

  • Two Seas Capital LP, Two Seas Capital GP LLC, and Sina Toussi (collectively, the "Reporting Persons") have filed Amendment No. 13 to their Schedule 13D.
  • The Reporting Persons' beneficial ownership in Indivior PLC has decreased to 6,211,854 Ordinary Shares, representing approximately 4.98% of the outstanding shares.
  • This percentage is based on 124,853,897 Ordinary Shares of Indivior PLC outstanding as of October 1, 2025, as disclosed in the Issuer's Form 10-Q filed on October 30, 2025.
  • The reduction in ownership means that as of December 19, 2025, the Reporting Persons ceased to beneficially own more than five percent of Indivior PLC's outstanding Ordinary Shares.
  • The shares are held by Two Seas Global (Master) Fund LP and Two Seas Litigation Opportunities Fund LLC (the "Funds"), with Two Seas Capital LP exercising sole voting and investment power.
  • Transactions since December 10, 2025, primarily involved sales of Ordinary Shares by both Funds, with prices ranging from $35.07 to $36.35 per share, and one purchase at $35.75 per share.

Sentiment

Score: 5

Explanation: This filing reports a change in beneficial ownership by an investment firm, reducing its stake below the 5% threshold. It does not contain information directly impacting the issuer's operational or financial performance, thus maintaining a neutral sentiment.

Stakeholder Impact

  • Shareholders: The reduction of a significant institutional investor's stake could lead to market speculation regarding the reasons for the divestment, potentially influencing short-term trading behavior.
  • Company Management: The company's management may need to assess the implications of a reduced stake by a previously significant shareholder, particularly if Two Seas Capital had an activist role or provided strategic input.

Key Dates

DateDescription
2022-06-16Original date of Credit Facility Agreement between Litigation Fund and UBS AG, London Branch.
2022-09-22First amendment and restatement of the Credit Facility Agreement.
2023-04-05Second amendment and restatement of the Credit Facility Agreement.
2023-06-19Third amendment and restatement of the Credit Facility Agreement.
2023-12-20Amendment to the Credit Facility Agreement.
2024-06-20Fifth Amendment Agreement, amending and restating the Credit Facility Agreement.
2024-12-20Sixth Amendment Agreement, amending and restating the Credit Facility Agreement.
2025-10-01Date as of which 124,853,897 Ordinary Shares of Indivior PLC were outstanding.
2025-10-30Date Indivior PLC's Form 10-Q was filed, disclosing outstanding shares.
2025-12-10Date of the previous Schedule 13D Amendment No. 12 filing.
2025-12-11Transactions by Two Seas Global (Master) Fund LP: sales of 75,000, 25,000, 50,000, and 100,000 shares at prices ranging from $35.70 to $35.94.
2025-12-12Transactions by Two Seas Global (Master) Fund LP: sales of 44,111, 100,000, and 150,000 shares, and purchase of 100,000 shares at prices ranging from $35.57 to $36.35.
2025-12-12Transaction by Two Seas Litigation Opportunities Fund LLC: sale of 55,889 shares at prices ranging from $36.00 to $36.02.
2025-12-19Date Reporting Persons ceased to beneficially own more than five percent of outstanding Ordinary Shares.
2025-12-19Transactions by Two Seas Global (Master) Fund LP: sale of 149,917 shares at prices ranging from $35.07 to $36.01.
2025-12-19Transaction by Two Seas Litigation Opportunities Fund LLC: sale of 200,083 shares at prices ranging from $35.07 to $36.01.
2025-12-23Date of Event Which Requires Filing of This Statement (Amendment No. 13).

Keywords

Indivior PLC, Two Seas Capital, Schedule 13D, beneficial ownership, stake reduction, pharmaceuticals, investment management

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.